The Efficacy and Safety of Palonosetron in Preventing the Gastrointestinal Reactions Induced by 3-day Highly Emetogenic Chemotherapy
Clinical trial NCT01909856 · COMPLETED
Trial details
- NCT number
- NCT01909856
- Sponsor
- Jiangsu Simcere Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-10-01
- Primary completion
- 2014-04-01
- Enrollment
- 92
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.